Location: Steinbeck Foyer

	Esthelle Hoedt, Ph.D PrognomIQ Esthelle Hoedt is a Senior Scientist at PrognomIQ. Her research focuses on the development, validation and deployment of clinical mass spectrometry assays for relative and accurate protein quantification in complex matrices. She received her PhD at Lille University of Sciences and Technology in France. As a Postdoctoral Fellow, she continued her research and training in the Mass Spectrometry Core Facility for Neuroscience at NYU, before working as a Senior Scientist at Caprion in Montreal, Canada. Prior to her current position, she focused on translating discovery proteomics assays to the clinic at Cedars Sinai Hospital in Los Angeles
	Kara Lynch, PhD, DABCC University of California San Francisco Dr. Kara Lynch is a Professor of Laboratory Medicine at the University of California San Francisco, Co-Director of the Core Laboratory at Zuckerberg San Francisco General Hospital and Chemistry Director at UCSF Benioff Children’s Hospital Oakland. She is the co-director of the COMACC-accredited Clinical Chemistry Fellowship Program at UCSF. Her laboratory conducts studies aimed at identifying and quantifying endogenous and exogenous small molecules in biological specimens using novel diagnostic technologies, such as high resolution mass spectrometry, ion mobility mass spectrometry, ambient ionization mass spectrometry and biolayer interferometry. Her lab is involved in translational research studies evaluating the clinical utility of novel biomarkers or biomarker panels to diagnosis, treat and monitor disease. The methods developed in her laboratory are used to investigate perturbations in metabolic pathways caused by disease and drug use and translate the results into information that can be used in clinical practice.
	Tim Garrett, PhD University of Florida College of Medicine Dr. Garrett has over 20 years of experience in the field of mass spectrometry spanning both instrument and application development. He received his PhD from the University of Florida, under Dr. Richard A. Yost, working on the first imaging mass spectrometry-based ion trap instrument. He has also developed MALDI-based approaches to analyze proteins in bacteria and small molecules in tissue specimens. His current interests include the translation of LC-HRMS, MALDI, DESI and LMJSSP in metabolomics to clinical diagnostics. He is an Associate Professor in the Department of Pathology at the University of Florida, and an Associate Director for the Southeast Center for Integrated Metabolomics (SECIM).
	Shannon Haymond, PhD Northwestern University Feinberg School of Medicine My lab performs research and clinical testing using mass spectrometry methods, develops new assays, and applies data analytics to enable improved quality and efficiency. My computational pathology efforts are aimed at building the capacity for advanced data analytics in the department through innovations in infrastructure, education, and research to facilitate data-informed decision making for clinical care, operations, and quality assurance.
	Stephen Master, MD, PhD, FADLM Children's Hospital of Philadelphia Stephen Master received his undergraduate degree in Molecular Biology from Princeton University, and subsequently obtained his MD and PhD from the University of Pennsylvania School of Medicine. After residency in Clinical Pathology at Penn, he stayed on as a faculty member with a research focus in mass spectrometry-based proteomics as well as extensive course development experience in bioinformatics. After time as an Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine in New York City, where he served as Director of the Central Lab and Chief of Clinical Chemistry Laboratory Services, he took a position at the Children's Hospital of Philadelphia at Chief of Lab Medicine. One of his current interests is in the applications of bioinformatics and machine learning for the development of clinical laboratory assays. He would play with R for fun even if he weren't getting paid, but he would appreciate it if you didn't tell that to his department chair.
	Prof. Dr. med. Michael Vogeser University Hospital, LMU Munich Dr. Michael Vogeser, MD, is specialist in Laboratory Medicine and senior physician at the Hospital of the University of the Ludwig-Maximilians-University Munich, Germany (LMU; Institute of Laboratory Medicine). As an Associate Professor he is teaching Clinical Chemistry and Laboratory Medicine. The main scope of his scientific work is the application of mass spectrometric technologies in routine clinical laboratory testing as translational diagnostics. Besides method development in therapeutic drug monitoring and endocrinology a further particular field of his work is quality and risk management in mass spectrometry and in clinical testing in general. Michael has published >240 articles in peer reviewed medical journals. Michael heads the Commission for In Vitro Diagnostics in the German Association of Scientific Medical Societies (AWMF).)
	Jessica Colón-Franco, PhD Cleveland Clinic Foundation Dr Jessica M Colón-Franco is Section Head of Clinical Biochemistry and Director of the Special Chemistry Laboratory at Cleveland Clinic, and adjunct faculty at Cleveland State University in Cleveland, OH. In her current role, Jessica provides strategic, clinical and scientific direction to the clinical laboratories in the section. Previously, Jessica was Director of Chemistry, Toxicology and Point-of-Care at Wisconsin Diagnostic Laboratories and Associate Professor at the Medical College of Wisconsin in Milwaukee, WI. Jessica obtained her bachelor’s degree in industrial biotechnology from the University of Puerto Rico at Mayagüez, Puerto Rico and her doctorate degree in Biochemistry and Molecular Biology from the Mayo Graduate School, College of Medicine in Rochester, MN. She completed a fellowship in Clinical Chemistry at Vanderbilt University Medical Center in Nashville, TN. Jessica is a diplomate of the American Board of Clinical Chemistry, fellow of the AACC Academy and is a member of several laboratory medicine associations, where she has served in various committee roles. Jessica’s interests are focused on endocrinology, therapeutic drug monitoring and toxicology, and inflammatory biomarkers.

1. Meetup for Black & Brown Scientists
Esthelle Hoedt

There is a growing appreciation for diversity, equity, and inclusion as drivers of excellence in the workplace in general, where Black and Brown scientists are extremely underrepresented. The goal of this roundtable is to ensure a safe place for full and meaningful conversations between Black and Brown Scientists. We will discuss our individual experiences in the analytical and/or clinical laboratory. Despite discrimination and continuing inequities, we have seen members of these communities rise to leadership roles in our societies. Let’s engage and help identify practices with demonstrated success with collaborative dialogue and identify the actions necessary to further positive change.

2. JMSACL Editors-in-Chief
Kara Lynch & Tim Garrett

The current path and future prospects for the journal. How to participate in or initiate Special Issues. Ask questions about submitting to the journal or being a reviewer.

3. Careers in Clinical Chemistry
Shannon Haymond & Stephen Master

4. IVDR : The Regulation Environment in the EU
Michael Vogeser

As of May 2022, the In Vitro Diagnostics Regulation (IVDR) regulates items (such as calibration and QC materials) manufactured and used in individual medical laboratories in the European Union. The interpretation of the IVDR is still controversial on several points.

5. Testing in Dried Spots, Microcollection Devices and Self-Collection: What’s trending?
Jessica Colon-Franco

The COVID-19 pandemic led to an unprecedented increase of digital health visits. This practice is seen as an effective strategy to manage patients with chronic diseases, although the long term sustainability and impact beyond the pandemic is still evolving. Decentralized sample collection for laboratory testing is projected as a major cornerstone to sustain telemedicine efforts, and could increase remote access to testing and outcomes. Although promising, the literature regarding self-collection and outcomes remains scarce. Moreover, only a few laboratories offer testing in these devices likely due to the technical limitations of these devices, and considerably increased technical and regulatory needs. The purpose of this roundtable is to foster a discussion about the potential clinical applications of testing in dried spots and other self-collection devices, some of the existing literature and technology, clinical practice trends, and foreseeable needs and gaps. The format will consist of presenting brief case studies/vignettes related to testing in these devices, followed by guided and open discussions.